Sensorion (FRA:RFM) Total Liabilities: €13.41 Mil (As of Dec. 2025)


FRA:RFM Sensorion SA FRA:RFM
29 GF Score
Price €0.22
! 1 Warning Sign
View Full Analysis

What is Sensorion Total Liabilities?

Sensorion FRA:RFM -6.99% 29 Total Liabilities is €13.41 Mil as of Dec. 2025. GuruFocus rates FRA:RFM with a GF Score™ of 29/100. The stock has 1 warning sign investors should review.

Sensorion's Total Liabilities for the quarter that ended in Dec. 2025 was €13.41 Mil.

Sensorion's quarterly Total Liabilities declined from Dec. 2024 (€17.14 Mil) to Jun. 2025 (€16.36 Mil) and declined from Jun. 2025 (€16.36 Mil) to Dec. 2025 (€13.41 Mil).

Sensorion's annual Total Liabilities increased from Dec. 2023 (€13.23 Mil) to Dec. 2024 (€17.14 Mil) but then declined from Dec. 2024 (€17.14 Mil) to Dec. 2025 (€13.41 Mil).

Sensorion Total Liabilities Historical Data

* Premium members only.

The historical data trend for Sensorion's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sensorion Total Liabilities Chart

Sensorion Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.03 17.06 13.23 17.14 13.41

Sensorion Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.23 18.07 17.14 16.36 13.41
FRA:RFM
29GF Score
Sensorion SA FRA:RFM
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sensorion Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sensorion's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.966+(0.124+1.009
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.309+0)
=13.41

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=57.887-44.479
=13.41

Sensorion's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.966+(0.124+1.009
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.309+0)
=13.41

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=57.887-44.479
=13.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €13.41 Mil mean?
Sensorion (FRA:RFM) has a Total Liabilities of €13.41 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sensorion and its competitors.
Is Sensorion's Total Liabilities too high?
Sensorion's current Total Liabilities is €13.41 Mil. Overall, Sensorion has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Sensorion's Total Liabilities compare to VRTX and REGN?
Sensorion's Total Liabilities of €13.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sensorion and its competitors. Sensorion's current Total Liabilities is €13.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensorion stock overvalued right now?
Sensorion (FRA:RFM) has a current Total Liabilities of €13.41 Mil. The current Total Liabilities is €13.41 Mil. Sensorion's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Sensorion (FRA:RFM), the current Total Liabilities is €13.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sensorion Business Description

Other Exchanges ALSEN:FranceRFM:Germany
Address 375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
29GF Score

Get the complete analysis for FRA:RFM

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.22
Price